Ignite Creation Date:
2024-05-06 @ 3:36 AM
Last Modification Date:
2024-10-26 @ 11:35 AM
Study NCT ID:
NCT02321501
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-10
First Post:
2014-12-17
Brief Title:
Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| ALK Positive |
| Locally Advanced Malignant Solid Neoplasm |
| Metastatic Malignant Solid Neoplasm |
| ROS1 Gene Rearrangement |
| Stage IIIB Lung Non-Small Cell Cancer AJCC v7 |
| Stage IV Lung Non-Small Cell Cancer AJCC v7 |
Keywords: